Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

Objectives Assess values, preferences and burden of treatment that patients with type 2 diabetes consider when initiating glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) compared with other glucose-lowering options.Methods Paired reviewers...

Descripción completa

Detalles Bibliográficos
Autores principales:	González González, José Gerardo, Díaz González Colmenero, Alejandro, Millán Alanís, Juan Manuel, Lytvyn, Lyubov, Solís, Ricardo Cesar, Mustafa, Reem A, Palmer, Suetonia C, Li, Sheyu, Hao, Qiukui, Alvarez Villalobos, Neri Alejandro, Vandvik, Per Olav, Rodríguez Gutiérrez, René
Formato:	Artículo
Lenguaje:	English
Publicado:	BMJ Publishing Group. 2021
Materias:	RC Medicina Interna, Psiquiatría, Neurología
Acceso en línea:	http://eprints.uanl.mx/25580/1/25580.pdf

Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

Ejemplares similares